Biological medicine treatment
Biological treatment shows promising results and major progress in treatment. Patients suffering from moderate to severe psoriasis who have not responded well to conventional systemic treatment or phototherapy are good candidates for this treatment. Diligent monitoring of the dermatologist is necessary when choosing biological therapy.
Biologicals are monoclonal bodies, small protein molecules that, by binding to specific inflammatory mediators, inhibit them and therefore inhibit the changes on the skin. Psoriatic arthritis responds well to this treatment. Subcutaneous injections or intravenous infusion is administered. This therapy shows rapid improvement in symptoms of patients, is relatively safe, has fewer side effects than conventional medications, and is more effective. Treatment with biologicals significantly improves the quality of life.
Prior to administering a biological, several tests are performed to establish the patient’s general health. Latent tuberculosis infection, hepatitis B and C, and HIV infections are to be ruled out. Regular check-ups with the dermatologist is necessary during treatment.